Background-The management of aortic intramural hematoma (IMH) involving the ascending aorta (type A) has not been well-established. The purpose of this study was to clarify the long-term clinical outcomes of patients with type A IMH who were treated with medical therapy and timely operation. Methods and Results-Clinical data including operative mortality, IMH-related events, and long-term survival were retrospectively reviewed in 66 patients with type A IMH, who were admitted to our institution from 1986 to 2006. Emergent surgical repair was performed in 16 (24%) patients because of severe complications, whereas 50 patients were treated with initial medical therapy. In medically treated patients, 15 (30%) patients who demonstrated progression to classic dissection or increase in hematoma size within 30 days underwent surgical repair except for 2 patients who refused surgery. The 30-day mortality rate was 6% with emergent surgery and 4% with supportive medial therapy. There were 7 late deaths and the actuarial survival rates of all patients were 96Ϯ3%, 94Ϯ3%, and 89Ϯ5% at 1, 5, and 10 years, respectively. In medically treated patients, maximum aortic diameter was the only predictor of early and late progression of ascending IMH (hazard ratio, 4.43; 95% CI, 2.04 -9.64; PϽ0.001). Aortic diameter Ն50 mm predicted progression of ascending IMH with the positive and negative value of 83% and 84%, respectively.
A ortic intramural hematoma (IMH) has been recognized as one of the variants of aortic dissection (AD), characterized primarily by aortic wall hematoma without intimal tear or direct flow communication between true and false lumen. [1] [2] [3] [4] [5] [6] IMH has been thought as a precursor or early stage of classic AD. Therefore, the general principles of the management of aortic IMH have been same as those for classic AD. 2, 3, 7, 8 Accordingly, it has been considered that early surgery should be required for patients with type A IMH because it tends to develop classic overt dissection or rupture. However, studies from Asian countries have reported favorable responses to medical treatment without surgical intervention in patients with type A IMH. 9 -13 We previously reported that mid-term outcomes of type A IMH patients who were treated with supportive medical therapy with timed operation were favorable. 9 Thus, overall agreement about the strategy for patient management has not yet been achieved.
Few data are available for the clinical outcomes beyond 10 years of follow-up. Because supportive medical therapy with timely operation has been performed at our institution in patients with type A IMH, we reviewed our experience to describe the long-term clinical outcomes for this population and to reconsider the therapeutic strategy for the disease.
Materials and Methods

Patient Characteristics
From 1986 to 2006, 298 patients with type A acute aortic syndrome were admitted to our institutions within 2 days from onset. Of these patients, there were 66 patients with type A IMH and 232 patients with type A classic AD. Diagnoses were established by contrastenhanced CT and transesophageal echocardiography (TEE). IMH was defined as a crescentic or circular high-attenuation area along the aortic wall without contrast enhancement in CT and regional aortic wall thickening in TEE without evidence of direct flow communication. 1 However, classic AD was defined as the dissection with visible intimal tear and flow communication between true and false lumen. Because ulcer-like projection (ULP) has been considered to represent the site of an intimal disruption, 14 patients who showed ULP or penetrating atherosclerotic ulcer (PAU) into the hematoma space on the initial CT were excluded even though imaging modalities showed typical crescent aortic wall thickness. Figure 1 summarizes the therapeutic strategy for patients with type A IMH. We managed the type A IMH patients with supportive medical therapy. Until 1999, if patients had complications with cardiac tamponade, they underwent pericardiocentesis and were followed-up medically. There were 7 patients who received pericardiocentesis, and 6 of these patients demonstrated the increase in hematoma size or progression to overt dissection. Considering high progression rates in patients with cardiac tamponade and technical improvements in aortic surgery, emergent surgery was recommended as an initial treatment in 2000 in patients complicated with cardiac tamponade or aortic regurgitation. As a result, emergent surgical repair was performed in 16 patients because of complications, including cardiac tamponade (nϭ9), aortic regurgitation (nϭ4), and impending rupture (nϭ3). However, 50 patients were initially treated with medical therapy. The protocol of supportive medical therapy in patients with type A IMH has been described previously. 9, 15 Close clinical follow-up using transthoracic echocardiography, TEE, and CT was performed to minimize the risk of fatal complications. Transthoracic echocardiography was performed daily during the initial 5 days to monitor pericardial effusion and aortic regurgitation. Follow-up CT or TEE was performed within 3 days after the admission and generally once per week after that until the third week after the admission. Patients who demonstrated an increase in hematoma size or progression to overt AD during the follow-up period were referred to surgical repair and underwent timely operation.
Treatment
Clinical follow-up data were obtained from patients in person or by telephone interview. Early progression was considered present with evolution to overt AD, increased hematoma size, progressive aortic enlargement, or aortic rupture after Յ30 days of hospital admission. Accordingly, late progression was considered present with evolution to overt AD, aortic enlargement to Ն55 mm in maximum diameter, or aortic rupture beyond 30 days. In addition, early (Յ30 days of hospital admission) and late (beyond 30 days) deaths were assessed. Furthermore, clinical characteristics and CT images were analyzed to identify risk factors of early and late progression of ascending IMH.
CT Measurement
Using initial CT performed within 48 hours after the onset, the representative ascending aortic images were selected at 3 levels to evaluate aortic diameter and hematoma thickness as previously described. 15 With the use of computerized planimetry, aortic diameter and hematoma thickness in the ascending aorta were measured in each of the slices. Maximum aortic diameter and maximum hematoma thickness were defined as the largest measure in all 3 slices.
Statistical Analysis
Categorical variables are described as number and percent and compared with the 2 test or Fisher exact test as appropriate. Continuous variables are described as meanϮSD except for operative days and survival rates and compared with unpaired t tests. Because operative days after the onset were not normally distributed, Mann-Whitney U test was performed to assess differences. Survival analysis was performed by Kaplan-Meier analysis and differences in survival between groups were examined with the log-rank test. To determine the predictors for progression of ascending IMH throughout follow-up period, Cox proportional hazards model was used to estimate the risk of the following potential variables: age, gender, hypertension, hyperlipidemia, diabetes, history of smoking, hemodialysis, cardiac tamponade, involvement of descending aorta, maximum aortic diameter (per 10-mm increments), and maximum hematoma thickness (per 5-mm increments). We plotted log (time) versus log [Ϫlog (survival)] stratified by each significant risk factor and evaluated whether the plotted lines were parallel. Those variables for which PϽ0.20 in univariate analyses and proportional assumptions were generally fair were included in the multivariate analysis. The multivariate Cox proportional hazard model was built by stepwise variable selection with entry and removal exit criteria set at the Pϭ0.05 and Pϭ0.10, respectively. Because of the small sample size, exact CI and P value are reported for the multivariable models. For additional comparison of the prognostic value of maximum aortic diameter with regard to progression of ascending IMH, receiveroperating characteristic curves were generated and the areas under the curves were calculated. PϽ0.05 was considered statistically significant. Data analyses were performed with SPSS software (version 17.0; SPSS, Inc, Chicago, Ill).
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The authors had full access to and take responsibility for the integrity of the data. All authors have read and agree to the manuscript as written. Table 1 summarizes the clinical features and outcomes of all patients in relation to initial treatment. In regard to 16 patients who underwent emergency surgery, no apparent tear was recognized with the operative findings. In 50 patients with initial medical therapy, 15 (30%) patients demonstrated early progression of ascending IMH. These patients underwent surgical repair (median, 8 days; range, 2-27 days after the onset), except for 2 patients who refused surgery and died of aortic rupture 3 and 26 days after the onset.
Results
Clinical Outcomes of Medical and Surgical Therapy
The 30-day mortality rate was 6% with emergent surgery and 4% with supportive medial therapy. Patients were followed-up from 1.7 to 17.7 years, with a mean of 7.6 years. After hospital discharge, 4 patients showed late progression to AD in the ascending aorta and 3 of these underwent operation 46, 86, and 122 days after the onset. In addition, 1 patient showed ascending aortic enlargement (aortic diameter Ն55 mm) at 25 months after the onset, and 2 patients who received medical therapy only showed progression to AD in the descending aorta 9 days and at 3 months after the onset, despite complete disappearance of ascending aortic lesion. The patients in whom AD of descending aorta develop were treated medically and did not need any surgical intervention. Figure 2 shows the freedom from IMH-related events including early and late progression of both the ascending and 
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descending aorta. As a result, a total of 16 patients underwent timely operation because of early or late progression of ascending IMH. Conversely, a total of 32 patients (48%) were discharged without operation. Among them, follow-up imaging study could be obtained in 31 patients (mean, 45 months after the onset). In these patients, the maximum hematoma thickness significantly decreased (from 9Ϯ4 mm to 0Ϯ1 mm; PϽ0.001; Figure 3 ). In addition, maximum aortic diameter significantly decreased (from 45Ϯ4 mm to 42Ϯ6 mm; Pϭ0.001; Figure 3 ). Complete resolution of intramural hematoma in the ascending aorta occurred in 30 patients (94%). There was no late death in patients with emergency operation. There were 4 late deaths in patients who received medical therapy only and the causes of deaths were heart failure (nϭ2), malignancy (nϭ2), and pneumonia (nϭ1). Besides, there were 3 late deaths in patients who underwent timely operation and the causes of deaths were heart failure, pneumonia, and cerebral infarction. None of the late deaths was related to IMH nor delayed operation. The actuarial survival rates of all 66 patients were 96Ϯ3, 94Ϯ3, and 89Ϯ5% at 1, 5, and 10 years ( Figure 4A ). There were no significant differences between the patients with emergent surgery and those with initial medical therapy with respect to actuarial survival rates (Pϭ0.63; Figure 4B ).
Operative mortality and morbidity of both emergent and timely surgery are summarized in Table 2 . There was only 1 (4%) operative death attributable to uncontrollable bleeding who underwent emergent surgery. There were 4 strokes including temporal (1 in timely surgery) and permanent severe strokes (1 in emergency surgery and 2 in timely surgery).
Appearance of ULP During Follow-Up
In the study cohort, 3 patients showed typical IMH-like crescent tomographic images and ULP in the descending aorta in the initial CT imaging. Because ULP has been considered to represent the site of an intimal disruption and flow communication, we diagnosed retrograde dissection with thrombosed false lumen in the ascending aorta and excluded from the study. 16 However, 8 patients showed new appearance of ULP in the ascending aorta during medical therapy in the follow-up CT images. The maximum hematoma thickness in these patients significantly increased than in the initial CT images (13Ϯ6 mm versus 27Ϯ7 mm; Pϭ0.005). All of these patients underwent timely surgical repair.
Predictors of Progression
In 50 patients with initial medical therapy, a total of 20 patients showed early (nϭ15) and late (nϭ5) progression of ascending IMH. Table 3 shows the results of univariate analysis for predictors of early and late progression of ascending IMH in medically treated patients. Aortic diameter ranged from 36 mm to 66 mm and was significantly larger in patients with progression than those without progression (PϽ0.001). Hematoma thickness ranged from 4 mm to 25 mm and was significantly larger in patients with progression than without progression (Pϭ0.002). Univariate analysis revealed maximum aortic diameter, hematoma thickness, and cardiac tamponade as the significant predictors (Table 4 ). On multivariate Cox regression analysis, maximum aortic diameter was confirmed as the only independent predictor of early and late progression (hazard ratio, 4.43; 95% CI, 2.04 -9.64; PϽ0.001). Receiver-operating characteristic curve analysis identified maximum aortic diameter Ն50 mm as a cutoff for predicting progression of ascending IMH (area under the curve, 0.88; 95% CI, 0.78 -0.97), with sensitivity, specificity, and positive and negative predictive values of 75% (95% CI, 60 -84), 90% (95% CI, 80 -96), 83% (95% CI, 66 -93), and 84% (95% CI, 75-90), respectively. Similarly, receiveroperating characteristic curve analysis identified maximum hematoma thickness Ն10 mm as a cut-off for predicting progression of ascending IMH (area under the curve, 0.74; 95% CI, 0.61-0.88), with sensitivity, specificity, and positive and negative predictive values of 75% (95% CI, 58 -87), 63% (95% CI, 52-72), 58% (95% CI, 45-67), and 79% (95% CI, 65-90), respectively. The survival rate free from early and late progression of ascending IMH was significantly higher in patients with the initial maximum aortic diameter Ͻ50 mm than those Ն50 mm (PϽ0.001; Figure 5 ).
Discussion
The main findings of this study were as follows: (1) longterm (10-year) clinical outcomes of type A IMH were favorable when the patients were treated with emergent surgery in complicated cases and otherwise supportive medical therapy with timely operation in cases with progression of hematoma; (2) occurrence of any relevant adverse clinical events after acute stage in medically treated patients was relatively low; and (3) the initial maximum aortic diameter was the strongest predictor for early and late progression of ascending IMH in medically treated patients.
There has been a controversy regarding the treatment of type A IMH. The most common therapeutic strategy for IMH has been the same as that for classic AD, because proximal location of IMH was considered an independent predictor of progression, contained rupture, or aneurysm formation. 2, 3, 7, 8 However, the evolution of type A IMH appears to be more benign than that of AD and studies from Asian countries reported low mortality rates in medically treated proximal IMH. 9 -13 Song et al 13 reported that 67% of medically treated type A IMH patients showed disappearance of hematoma. In addition, we previously reported that patients with type A IMH could be favorably managed with supportive medical therapy and timed operation, and mid-term outcomes of these patients were acceptable. 9 On the contrary, von Kodolitsch et al 17 reported that medically treated type A IMH patients showed worse prognosis than surgically treated patients. Recent technical improvements in emergent surgery for acute aortic syndrome have resulted in reduced operative mortality. 18, 19 In the present study, 20 patients with early and late progressions were successfully converted to surgical repair during follow-up except for 3 patients who refused operation and the remaining 30 patients could be managed medically alone. Besides, "delayed" surgery did not increase mortality.
Considering similar results of operative mortality and morbidity between emergency and "delayed" operation, individualized "wait and see" strategy does not seem to increase the risk in the management of type A IMH. Thus, we propose combination of medical therapy and timely operation in cases with complication or progression of IMH as a rational therapeutic option.
In the present study, the diagnostic frequency of IMH was higher than those in the previous studies from the western countries, 2, 4, 5, 20 which might lead to the different clinical outcomes. A recent meta-analysis study reported that frequency of aortic type A IMH was significantly higher and the mortality rate with medical therapy was lower in Japan/Korea than in North America/European countries. 21 These international heterogeneities may be partially attributable to a genetic factor. Otherwise, the inclusion of more subtle IMH, potentially indicative of less severe or more stable cases, may have lead to improved outcomes with medical therapy in Japan/Korea.
Absence of direct flow communication between true and false lumen is considered as a critical criterion to differentiate AD from IMH. In the present study, if a patient has direct flow communication between hematoma and true lumen of the ascending or arch aorta, we regarded that IMH progressed to AD and referred the patient to surgery. Therefore, it must be very important to detect whether flow communication exists in both initial and follow-up imaging studies. 22 For this purpose, TEE must be extremely useful. 1 Furthermore, multidetector row CT might provide more accurate diagnosis. Thus, we reasoned that close observation with multiple imaging modalities is necessary to avoid overlooking progression of IMH.
It has been reported that late progression might occur in patients with persistent IMH. 9, 11 In the present study, 5 patients showed late progression to AD or aortic enlargement in the ascending aorta, whereas 1 other patient showed late progression to AD in the descending aorta. All these patients with late progressions were asymptomatic and in stable conditions. Besides, survival after initial 30 days was good despite the late progression. Thus, late progression was relatively rare and not life-threatening compared to early progression. However, regular imaging follow-up after the hospital discharge should be recommended to evaluate the morphological changes of both the ascending and descending aorta. To achieve better outcomes of patients with type A IMH, it would be helpful to establish risk factors of the adverse outcomes. We previously reported that maximum ascending aortic diameter Ն50 mm in the initial CT images was the strongest risk factor for early progression of ascending IMH. 15 It has also been reported that hematoma size Ն11 mm in the initial images was the risk factor. 22 However, these studies were limited by relatively small population and short follow-up duration. The present study, based on the clinical results with larger patient population and longer follow-up duration, revealed that the strongest risk factor for both early and late progression of ascending IMH was ascending aortic diameter Ն50 mm. Risk stratification may allow drawing the optimal therapeutic strategy of type A IMH. For instance, if aortic diameter was Ն50 mm, prophylactic emergent surgery might be beneficial to reduce the risk of mortality and shorten the hospital stay.
Cardiac tamponade is the important issue in the treatment of type A IMH. Several studies reported the successful medical management with pericardiothentesis. 9, 12, 13, 15 However, medical management for patients with cardiac tamponade is generally believed to be challenging. In the present study, univariate analysis revealed that cardiac tamponade was the risk factor for progression of ascending IMH. Considering the pathophysiology of cardiac tamponade in type A IMH, 23 we believe that patients with tamponade should be treated with emergent surgery.
Our study has several limitations. First, we excluded patients who showed ULP or PAU in the initial CT images, because the definition of IMH with ULP or PAU was complicated by confusing and overlapping medical terminology. 14, 20, 24, 25 Besides, it was regarded as AD with thrombosed false lumen in several works of literature. 16, 25 Because ULP and PAU were reported to be the risk factors for the progressive disease course, 14, 20 exclusions of these patients might lead to better clinical outcomes. Further studies are necessary to understand the pathophysiology of ULP and PAU associated with IMH. Second, although we diagnosed IMH with the combination of CT and TEE, it might be possible to overlook small intimal tear, ULP, and PAU in the first imaging examination. This is the limitation of the imaging technology available during the study period and further improvements of imaging technology may lead to better understanding of IMH. Third, relatively small sample size may not have sufficient power to detect possible risk factors for progression of ascending IMH. Consequently, predictive factors of an only moderate relative risk may have been missed. Finally, we could repeat diagnostic imaging in medically treated patients. Frequent diagnostic imaging was accepted and financially covered by the National Health Insurance System in Japan, which was advantage of this study. However, our strategy may lead to considerable increase of in-hospital stay and medical costs. Further studies are necessary for therapeutic strategy including operative timing from the view point of cost-effectiveness.
Clinical Implications
Based on our data, medical therapy with or without timely operation resulted in favorable long-term results. Thus, prophylactic emergent surgery may not be always necessary for patients with type A IMH. However, medical treatment alone was not enough to manage all type A IMH patients. We think that emergent surgery should be recommended in complicated case with cardiac tamponade, myocardial ischemia, and aortic regurgitation. If patients do not have complications, supportive medical therapy with frequent imaging follow-up can be a rational option. In these cases, timely surgery should be considered if hematoma shows progression. Alternatively, we may have to consider prophylactic emergent surgery for patients at high risk with ascending aortic diameter Ն50 mm. With our strategy, close imaging follow-up with multiple modalities is essential for all medically treated patients, because IMH may progress even in patients with aortic diameter Ͻ50 mm. Although further study is still necessary to determine the optimal timing of surgery, the combination of medical therapy and timely operation can be a rational therapeutic strategy for patients with type A IMH.
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